Literature DB >> 16785138

Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone.

Luisa Tavecchia1, Nicoletta Masera, Pierluigi Russo, Antonio Cirò, Antonella Vincenzi, Chiara Vimercati, Giuseppe Masera.   

Abstract

We report the case of a 25-years-old male with beta-thalassemia major who developed acute heart failure, with severe systolic dysfunction, resulting from iron overload. Combined iron chelation with desferrioxamine and deferiprone together with standard cardiological treatment induced prompt and complete restoration of the cardiac function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785138

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  6 in total

Review 1.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.

Authors:  Vassilios Ladis; Giorgos Chouliaras; Vasilios Berdoukas; Panagiotis Moraitis; Kirykos Zannikos; Eleni Berdoussi; Christos Kattamis
Journal:  Eur J Haematol       Date:  2010-08-30       Impact factor: 2.997

3.  Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Authors:  Athanasios Aessopos; Vasilios Berdoukas
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-18       Impact factor: 2.576

4.  The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study.

Authors:  Vasilios Berdoukas; Giorgos Chouliaras; Panagiotis Moraitis; Kirykos Zannikos; Eleni Berdoussi; Vassilios Ladis
Journal:  J Cardiovasc Magn Reson       Date:  2009-06-28       Impact factor: 5.364

5.  Treating thalassemia major-related iron overload: the role of deferiprone.

Authors:  Vasilios Berdoukas; Kallistheni Farmaki; Susan Carson; John Wood; Thomas Coates
Journal:  J Blood Med       Date:  2012-10-19

6.  Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective.

Authors:  Renzo Galanello
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.